Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.14
OMCL's Cash-to-Debt is ranked lower than
93% of the 1984 Companies
in the Global Health Information Services industry.

( Industry Median: 6.56 vs. OMCL: 0.14 )
Ranked among companies with meaningful Cash-to-Debt only.
OMCL' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14  Med: No Debt Max: No Debt
Current: 0.14
Equity-to-Asset 0.49
OMCL's Equity-to-Asset is ranked lower than
64% of the 1901 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. OMCL: 0.49 )
Ranked among companies with meaningful Equity-to-Asset only.
OMCL' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.57  Med: 0.69 Max: 0.78
Current: 0.49
-0.57
0.78
Debt-to-Equity 0.43
OMCL's Debt-to-Equity is ranked lower than
63% of the 1109 Companies
in the Global Health Information Services industry.

( Industry Median: 0.26 vs. OMCL: 0.43 )
Ranked among companies with meaningful Debt-to-Equity only.
OMCL' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.43  Med: 0.06 Max: 0.59
Current: 0.43
-0.43
0.59
Debt-to-EBITDA 4.84
OMCL's Debt-to-EBITDA is ranked lower than
84% of the 1011 Companies
in the Global Health Information Services industry.

( Industry Median: 1.30 vs. OMCL: 4.84 )
Ranked among companies with meaningful Debt-to-EBITDA only.
OMCL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.92  Med: 3.92 Max: 4.84
Current: 4.84
3.92
4.84
Piotroski F-Score: 3
Altman Z-Score: 3.54
Beneish M-Score: -2.84
WACC vs ROIC
6.83%
-0.66%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % -2.19
OMCL's Operating Margin % is ranked lower than
69% of the 1924 Companies
in the Global Health Information Services industry.

( Industry Median: 4.78 vs. OMCL: -2.19 )
Ranked among companies with meaningful Operating Margin % only.
OMCL' s Operating Margin % Range Over the Past 10 Years
Min: -2.19  Med: 7.72 Max: 11.25
Current: -2.19
-2.19
11.25
Net Margin % -1.14
OMCL's Net Margin % is ranked lower than
66% of the 1925 Companies
in the Global Health Information Services industry.

( Industry Median: 3.43 vs. OMCL: -1.14 )
Ranked among companies with meaningful Net Margin % only.
OMCL' s Net Margin % Range Over the Past 10 Years
Min: -1.14  Med: 5.1 Max: 20.32
Current: -1.14
-1.14
20.32
ROE % -1.80
OMCL's ROE % is ranked lower than
68% of the 1866 Companies
in the Global Health Information Services industry.

( Industry Median: 6.42 vs. OMCL: -1.80 )
Ranked among companies with meaningful ROE % only.
OMCL' s ROE % Range Over the Past 10 Years
Min: -1.8  Med: 5.35 Max: 25.13
Current: -1.8
-1.8
25.13
ROA % -0.85
OMCL's ROA % is ranked lower than
64% of the 1992 Companies
in the Global Health Information Services industry.

( Industry Median: 2.97 vs. OMCL: -0.85 )
Ranked among companies with meaningful ROA % only.
OMCL' s ROA % Range Over the Past 10 Years
Min: -0.85  Med: 4.01 Max: 17.93
Current: -0.85
-0.85
17.93
ROC (Joel Greenblatt) % -12.23
OMCL's ROC (Joel Greenblatt) % is ranked lower than
69% of the 1954 Companies
in the Global Health Information Services industry.

( Industry Median: 21.87 vs. OMCL: -12.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
OMCL' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -12.23  Med: 45.83 Max: 91.06
Current: -12.23
-12.23
91.06
3-Year Revenue Growth Rate 20.90
OMCL's 3-Year Revenue Growth Rate is ranked higher than
83% of the 1618 Companies
in the Global Health Information Services industry.

( Industry Median: 5.30 vs. OMCL: 20.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
OMCL' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -53.3  Med: 10.6 Max: 20.9
Current: 20.9
-53.3
20.9
3-Year EBITDA Growth Rate 5.50
OMCL's 3-Year EBITDA Growth Rate is ranked lower than
53% of the 1432 Companies
in the Global Health Information Services industry.

( Industry Median: 7.30 vs. OMCL: 5.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
OMCL' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -13.6  Med: 18 Max: 121.1
Current: 5.5
-13.6
121.1
3-Year EPS without NRI Growth Rate -69.00
OMCL's 3-Year EPS without NRI Growth Rate is ranked lower than
97% of the 1341 Companies
in the Global Health Information Services industry.

( Industry Median: 8.10 vs. OMCL: -69.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
OMCL' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -69.7  Med: 7.5 Max: 260.9
Current: -69
-69.7
260.9
GuruFocus has detected 8 Warning Signs with Omnicell Inc OMCL.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» OMCL's 30-Y Financials

Financials (Next Earnings Date: 2017-10-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

OMCL Guru Trades in Q3 2016

Ken Fisher 517,464 sh (-3.49%)
» More
Q4 2016

OMCL Guru Trades in Q4 2016

Jim Simons 23,243 sh (New)
Steven Cohen 33,900 sh (New)
Ken Fisher 507,114 sh (-2.00%)
» More
Q1 2017

OMCL Guru Trades in Q1 2017

Mariko Gordon 1,537,954 sh (New)
Jim Simons Sold Out
Steven Cohen Sold Out
Ken Fisher 492,314 sh (-2.92%)
» More
Q2 2017

OMCL Guru Trades in Q2 2017

Joel Greenblatt 33,566 sh (New)
Ken Fisher 492,202 sh (-0.02%)
Mariko Gordon 1,353,369 sh (-12.00%)
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2017-06-30 Reduce -12.00%0.44%$39.55 - $44.4 $ 53.5529%1,353,369
Ken Fisher 2017-06-30 Reduce -0.02%$39.55 - $44.4 $ 53.5529%492,202
Joel Greenblatt 2017-06-30 New Buy0.02%$39.55 - $44.4 $ 53.5529%33,566
Mariko Gordon 2017-03-31 New Buy3.64%$32.15 - $40.65 $ 53.5545%1,537,954
Ken Fisher 2017-03-31 Reduce -2.92%$32.15 - $40.65 $ 53.5545%492,314
Ken Fisher 2016-12-31 Reduce -2.00%$31.2 - $37.95 $ 53.5556%507,114
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 621999    SIC: 8099
Compare:SZSE:300253, NYSE:TDOC, NAS:PINC, NYSE:EVH, NAS:INOV, NAS:WBMD, SZSE:300451, NAS:QSII, XTER:COP, LSE:EMIS, NAS:HSTM, NAS:HQY, NAS:NH, XPAR:CGM, NAS:TRHC, SZSE:300550, LSE:CRW, SHSE:603990, ASX:PME, NAS:CPSI » details
Traded in other countries:OC9.Germany,
Headquarter Location:USA
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.

Omnicell provides automation and business analytics software for healthcare providers. The firm operates in two segments: automation and analytics and medication adherence. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. This segment contributes the majority of revenue. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

Ratios

vs
industry
vs
history
Forward PE Ratio 25.51
OMCL's Forward PE Ratio is ranked lower than
53% of the 298 Companies
in the Global Health Information Services industry.

( Industry Median: 22.88 vs. OMCL: 25.51 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
Price-to-Owner-Earnings 58.08
OMCL's Price-to-Owner-Earnings is ranked lower than
79% of the 744 Companies
in the Global Health Information Services industry.

( Industry Median: 25.49 vs. OMCL: 58.08 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
OMCL' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.72  Med: 40.78 Max: 3988.33
Current: 58.08
7.72
3988.33
PB Ratio 4.46
OMCL's PB Ratio is ranked lower than
62% of the 1848 Companies
in the Global Health Information Services industry.

( Industry Median: 3.13 vs. OMCL: 4.46 )
Ranked among companies with meaningful PB Ratio only.
OMCL' s PB Ratio Range Over the Past 10 Years
Min: 0.96  Med: 2.36 Max: 6.89
Current: 4.46
0.96
6.89
PS Ratio 2.95
OMCL's PS Ratio is ranked lower than
55% of the 1840 Companies
in the Global Health Information Services industry.

( Industry Median: 2.37 vs. OMCL: 2.95 )
Ranked among companies with meaningful PS Ratio only.
OMCL' s PS Ratio Range Over the Past 10 Years
Min: 0.94  Med: 2.16 Max: 4.69
Current: 2.95
0.94
4.69
Price-to-Free-Cash-Flow 35.73
OMCL's Price-to-Free-Cash-Flow is ranked lower than
62% of the 681 Companies
in the Global Health Information Services industry.

( Industry Median: 26.25 vs. OMCL: 35.73 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
OMCL' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.02  Med: 30.59 Max: 295
Current: 35.73
8.02
295
Price-to-Operating-Cash-Flow 28.51
OMCL's Price-to-Operating-Cash-Flow is ranked lower than
69% of the 850 Companies
in the Global Health Information Services industry.

( Industry Median: 18.64 vs. OMCL: 28.51 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
OMCL' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.98  Med: 20.69 Max: 10100
Current: 28.51
6.98
10100
EV-to-EBIT -145.92
OMCL's EV-to-EBIT is ranked lower than
99.99% of the 1275 Companies
in the Global Health Information Services industry.

( Industry Median: 19.16 vs. OMCL: -145.92 )
Ranked among companies with meaningful EV-to-EBIT only.
OMCL' s EV-to-EBIT Range Over the Past 10 Years
Min: -146.68  Med: 23.3 Max: 253.4
Current: -145.92
-146.68
253.4
EV-to-EBITDA 54.04
OMCL's EV-to-EBITDA is ranked lower than
85% of the 1386 Companies
in the Global Health Information Services industry.

( Industry Median: 15.27 vs. OMCL: 54.04 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMCL' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.7  Med: 15.5 Max: 54.32
Current: 54.04
3.7
54.32
EV-to-Revenue 3.20
OMCL's EV-to-Revenue is ranked lower than
57% of the 1894 Companies
in the Global Health Information Services industry.

( Industry Median: 2.40 vs. OMCL: 3.20 )
Ranked among companies with meaningful EV-to-Revenue only.
OMCL' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.4  Med: 1.9 Max: 4.3
Current: 3.2
0.4
4.3
Shiller PE Ratio 124.05
OMCL's Shiller PE Ratio is ranked lower than
87% of the 336 Companies
in the Global Health Information Services industry.

( Industry Median: 38.33 vs. OMCL: 124.05 )
Ranked among companies with meaningful Shiller PE Ratio only.
OMCL' s Shiller PE Ratio Range Over the Past 10 Years
Min: 36.8  Med: 56.58 Max: 124.75
Current: 124.05
36.8
124.75
Current Ratio 1.40
OMCL's Current Ratio is ranked lower than
67% of the 1846 Companies
in the Global Health Information Services industry.

( Industry Median: 1.89 vs. OMCL: 1.40 )
Ranked among companies with meaningful Current Ratio only.
OMCL' s Current Ratio Range Over the Past 10 Years
Min: 0.64  Med: 2.4 Max: 5.21
Current: 1.4
0.64
5.21
Quick Ratio 1.01
OMCL's Quick Ratio is ranked lower than
79% of the 1846 Companies
in the Global Health Information Services industry.

( Industry Median: 1.75 vs. OMCL: 1.01 )
Ranked among companies with meaningful Quick Ratio only.
OMCL' s Quick Ratio Range Over the Past 10 Years
Min: 0.4  Med: 2.02 Max: 4.95
Current: 1.01
0.4
4.95
Days Inventory 71.61
OMCL's Days Inventory is ranked lower than
79% of the 1139 Companies
in the Global Health Information Services industry.

( Industry Median: 17.56 vs. OMCL: 71.61 )
Ranked among companies with meaningful Days Inventory only.
OMCL' s Days Inventory Range Over the Past 10 Years
Min: 35.43  Med: 54.71 Max: 71.61
Current: 71.61
35.43
71.61
Days Sales Outstanding 81.04
OMCL's Days Sales Outstanding is ranked lower than
63% of the 1588 Companies
in the Global Health Information Services industry.

( Industry Median: 66.91 vs. OMCL: 81.04 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMCL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.2  Med: 69.17 Max: 84.02
Current: 81.04
56.2
84.02
Days Payable 50.90
OMCL's Days Payable is ranked higher than
55% of the 1405 Companies
in the Global Health Information Services industry.

( Industry Median: 42.91 vs. OMCL: 50.90 )
Ranked among companies with meaningful Days Payable only.
OMCL' s Days Payable Range Over the Past 10 Years
Min: 26.08  Med: 34.86 Max: 50.9
Current: 50.9
26.08
50.9

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.50
OMCL's 3-Year Average Share Buyback Ratio is ranked higher than
61% of the 1345 Companies
in the Global Health Information Services industry.

( Industry Median: -3.00 vs. OMCL: -1.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMCL' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -140.8  Med: -3.3 Max: 1.6
Current: -1.5
-140.8
1.6

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.30
OMCL's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
51% of the 811 Companies
in the Global Health Information Services industry.

( Industry Median: 2.20 vs. OMCL: 2.30 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
OMCL' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.94  Med: 1.52 Max: 8.67
Current: 2.3
0.94
8.67
Price-to-Median-PS-Value 1.36
OMCL's Price-to-Median-PS-Value is ranked lower than
61% of the 1639 Companies
in the Global Health Information Services industry.

( Industry Median: 1.12 vs. OMCL: 1.36 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
OMCL' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.25  Med: 1.03 Max: 2.28
Current: 1.36
0.25
2.28
Earnings Yield (Greenblatt) % -0.69
OMCL's Earnings Yield (Greenblatt) % is ranked lower than
67% of the 1997 Companies
in the Global Health Information Services industry.

( Industry Median: 2.11 vs. OMCL: -0.69 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
OMCL' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -0.8  Med: 4 Max: 19
Current: -0.69
-0.8
19
Forward Rate of Return (Yacktman) % 10.68
OMCL's Forward Rate of Return (Yacktman) % is ranked lower than
52% of the 818 Companies
in the Global Health Information Services industry.

( Industry Median: 11.39 vs. OMCL: 10.68 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
OMCL' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -2.5  Med: 26 Max: 43.9
Current: 10.68
-2.5
43.9

More Statistics

Revenue (TTM) (Mil) $680.15
EPS (TTM) $ -0.21
Beta0.81
Short Percentage of Float10.02%
52-Week Range $30.35 - 54.03
Shares Outstanding (Mil)37.45

Analyst Estimate

Dec17 Dec18 Dec19 Dec20
Revenue (Mil $) 734 822 951 1,088
EPS ($) 1.30 2.11 2.72 3.26
EPS without NRI ($) 1.30 2.11 2.72 3.26
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 33
Positive ROAN
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}